Stay updated on FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial

Sign up to get notified when there's something new on the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The footer revision marker changes from v3.7.0 to v3.7.1 while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-08T22:06:02.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with a simple header and navigation. This indicates restricted access to the study record rather than substantive content changes.
    Difference
    18%
    Check dated 2026-09-24T21:32:23.000Z thumbnail image
  4. Check
    49 days ago
    Change Detected
    Summary
    Added a note about the 2018 U.S. NIH Grant/Contract and updated the revision to v3.6.6, with the previous revision v3.6.5 removed.
    Difference
    0.1%
    Check dated 2026-08-27T19:43:39.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    Outage banners at the top of the page have been removed. The page now presents the study details without the prior global service disruption notice.
    Difference
    0.1%
    Check dated 2026-08-20T19:31:23.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Sitewide outage warning and a note about intermittent delays to NCBI services were added, indicating a temporary service disruption. The previous revision tag v3.6.4 was removed and updated to v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-13T19:27:11.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Added metadata about the study's last known status, sponsor, and last verification date, and removed the note indicating no longer recruiting participants, altering how the page presents current enrollment information.
    Difference
    0.3%
    Check dated 2026-08-06T12:37:30.000Z thumbnail image

Stay in the know with updates to FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FOLFIRI + Durvalumab vs FOLFIRI + Durvalumab + Tremelimumab Clinical Trial page.